gilead sciences inc (GILD:NASDAQ GS)
Richard J. Whitley M.D., Ph.D.
Independent Director, Member of Independent Health Policy Advisory Board, Chairman of Scientific Committee and Member of Nominating & Corporate Governance Committee, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 154 board members in 18 different organizations across 24 different industries.|
See Board Relationships
Dr. Richard J. Whitley, also known as Rich, M.D., Ph.D. is an Advisor of Vaxart, Inc. Dr. Whitley serves as Divisional Director of Pediatric Infectious Diseases, Vice Chairman of Department of Pediatrics, Senior Scientist of Department of Gene Therapy, Senior Scientist of Cancer Research and Training Center, Associate Director for Clinical Studies of Center for AIDS Research, Director of Center for Biodefense and Emerging Infections at The University of Alabama at Birmingham. ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*
Former Director and Member of Compensation Committee
Director and Chairman of Compensation Committee
Director, Chairman of Scientific Committee and Member of Nominating & Governance Committee
Independent Director, Member of Independent Health Policy Advisory Board, Chairman of Scientific Committee and Member of Nominating & Corporate Governance Committee
George Washington University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|